Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis

BACKGROUND: Lung cancer (LC) is a common malignant tumor with a high incidence and poor prognosis. Early LC could be cured, but the 5-year-survival rate for patients advanced is extremely low. Early screening of tumor biomarkers through plasma could allow more LC to be detected at an early stage, le...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongyu, Lai, Xiaoqin, Zhu, Yihan, Huang, Hong, Zeng, Lingyan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677906/
https://www.ncbi.nlm.nih.gov/pubmed/36404333
http://dx.doi.org/10.1186/s12014-022-09381-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677906/
https://www.ncbi.nlm.nih.gov/pubmed/36404333
http://dx.doi.org/10.1186/s12014-022-09381-x

Ejemplares similares